Posted: Dec 18, 2015 by ITOG Administrator

Update on ITOG Selumetinib Trial

Dr. Alan Ho
The selumetinib clinical trial led by Dr. Alan Ho of Memorial Sloan Kettering Cancer Center in New York, NY is now open. The trial evaluates the effectiveness of selumetinib to enhance uptake of radioactive iodine (RAI) for treatment of advanced thyroid cancer. This is a large, multicenter,...

Posted: Dec 18, 2015 by ITOG Administrator

Philanthropy Exceeds $2.5 Million

Support for the ITOG mission continues to grow with generous contributions from even more supportive donors. Most donations have come from patients, and families of patients, with thyroid cancer who believe that the multi-disciplinary team of ITOG physicians are making a significant difference in...

Posted: Oct 17, 2013 by Yariv Houvras

TA Associates Realty Selects ITOG as Charitable Beneficiary

TA Associates Realty is one of the leading investors in commercial real estate in the United States.  Michael Ruane, a founding member of TA Associates Realty, created an event to provide a valuable business gathering, golf at exceptional courses and raise funds to donate to worthy charities...

Posted: Dec 19, 2012 by Yariv Houvras

Philanthropy Reaches $1,000,000

Megan Larkin Curry and her mother Maureen Larkin
December, 2012: ITOG records its best year to date in fund raising. Since its inception in 2007, donations to ITOG have primarily come from individuals who have been personally affected by thyroid cancer. The Larkin Family, pictured, have raised over $80,000 for ITOG through its annual Kel Klassic...


International Thyroid Oncology Group
5166 Commercial Drive
Yorkville, New York 13495